BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33231931)

  • 1. Empirically downgrading 10 constitutional missense variants of the NF1 gene based on co-existing truncating variants.
    Kluwe L; Mautner VF
    Am J Med Genet A; 2021 Feb; 185(2):602-603. PubMed ID: 33231931
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1.
    Xiao H; Yuan L; Xu H; Yang Z; Huang F; Song Z; Yang Y; Zeng C; Deng H
    J Mol Neurosci; 2018 Aug; 65(4):557-563. PubMed ID: 30046999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromin (NF1) genetic variant structure-function analyses using a full-length mouse cDNA.
    Wallis D; Li K; Lui H; Hu K; Chen MJ; Li J; Kang J; Das S; Korf BR; Kesterson RA
    Hum Mutat; 2018 Jun; 39(6):816-821. PubMed ID: 29522274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.
    Koczkowska M; Chen Y; Callens T; Gomes A; Sharp A; Johnson S; Hsiao MC; Chen Z; Balasubramanian M; Barnett CP; Becker TA; Ben-Shachar S; Bertola DR; Blakeley JO; Burkitt-Wright EMM; Callaway A; Crenshaw M; Cunha KS; Cunningham M; D'Agostino MD; Dahan K; De Luca A; Destrée A; Dhamija R; Eoli M; Evans DGR; Galvin-Parton P; George-Abraham JK; Gripp KW; Guevara-Campos J; Hanchard NA; Hernández-Chico C; Immken L; Janssens S; Jones KJ; Keena BA; Kochhar A; Liebelt J; Martir-Negron A; Mahoney MJ; Maystadt I; McDougall C; McEntagart M; Mendelsohn N; Miller DT; Mortier G; Morton J; Pappas J; Plotkin SR; Pond D; Rosenbaum K; Rubin K; Russell L; Rutledge LS; Saletti V; Schonberg R; Schreiber A; Seidel M; Siqveland E; Stockton DW; Trevisson E; Ullrich NJ; Upadhyaya M; van Minkelen R; Verhelst H; Wallace MR; Yap YS; Zackai E; Zonana J; Zurcher V; Claes K; Martin Y; Korf BR; Legius E; Messiaen LM
    Am J Hum Genet; 2018 Jan; 102(1):69-87. PubMed ID: 29290338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.
    Isakov O; Wallis D; Evans DG; Ben-Shachar S
    EBioMedicine; 2018 Oct; 36():508-516. PubMed ID: 30274822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype-phenotype study in neurofibromatosis type 1.
    Koczkowska M; Callens T; Chen Y; Gomes A; Hicks AD; Sharp A; Johns E; Uhas KA; Armstrong L; Bosanko KA; Babovic-Vuksanovic D; Baker L; Basel DG; Bengala M; Bennett JT; Chambers C; Clarkson LK; Clementi M; Cortés FM; Cunningham M; D'Agostino MD; Delatycki MB; Digilio MC; Dosa L; Esposito S; Fox S; Freckmann ML; Fauth C; Giugliano T; Giustini S; Goetsch A; Goldberg Y; Greenwood RS; Griffis C; Gripp KW; Gupta P; Haan E; Hachen RK; Haygarth TL; Hernández-Chico C; Hodge K; Hopkin RJ; Hudgins L; Janssens S; Keller K; Kelly-Mancuso G; Kochhar A; Korf BR; Lewis AM; Liebelt J; Lichty A; Listernick RH; Lyons MJ; Maystadt I; Martinez Ojeda M; McDougall C; McGregor LK; Melis D; Mendelsohn N; Nowaczyk MJM; Ortenberg J; Panzer K; Pappas JG; Pierpont ME; Piluso G; Pinna V; Pivnick EK; Pond DA; Powell CM; Rogers C; Ruhrman Shahar N; Rutledge SL; Saletti V; Sandaradura SA; Santoro C; Schatz UA; Schreiber A; Scott DA; Sellars EA; Sheffer R; Siqveland E; Slopis JM; Smith R; Spalice A; Stockton DW; Streff H; Theos A; Tomlinson GE; Tran G; Trapane PL; Trevisson E; Ullrich NJ; Van den Ende J; Schrier Vergano SA; Wallace SE; Wangler MF; Weaver DD; Yohay KH; Zackai E; Zonana J; Zurcher V; Claes KBM; Eoli M; Martin Y; Wimmer K; De Luca A; Legius E; Messiaen LM
    Hum Mutat; 2020 Jan; 41(1):299-315. PubMed ID: 31595648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF1 mutations and molecular testing.
    Thomson SA; Fishbein L; Wallace MR
    J Child Neurol; 2002 Aug; 17(8):555-61; discussion 571-2, 646-51. PubMed ID: 12403553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the potential pathogenicity of missense mutations identified in the GTPase-activating protein (GAP)-related domain of the neurofibromatosis type-1 (NF1) gene.
    Thomas L; Richards M; Mort M; Dunlop E; Cooper DN; Upadhyaya M
    Hum Mutat; 2012 Dec; 33(12):1687-96. PubMed ID: 22807134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-silico Analysis of
    Accetturo M; Bartolomeo N; Stella A
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979111
    [No Abstract]   [Full Text] [Related]  

  • 10. Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I.
    Li K; Turner AN; Chen M; Brosius SN; Schoeb TR; Messiaen LM; Bedwell DM; Zinn KR; Anastasaki C; Gutmann DH; Korf BR; Kesterson RA
    Dis Model Mech; 2016 Jul; 9(7):759-67. PubMed ID: 27482814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Arg1038Gly missense variant in the NF1 gene causes a mild phenotype without neurofibromas.
    Trevisson E; Morbidoni V; Forzan M; Daolio C; Fumini V; Parrozzani R; Cassina M; Midena E; Salviati L; Clementi M
    Mol Genet Genomic Med; 2019 May; 7(5):e616. PubMed ID: 30843352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a missense mutation causing exon skipping in a neurofibromatosis type 1 patient.
    Fu Y; Zhang JQ; Jiang CL; Wang HY
    J Dermatol; 2018 Aug; 45(8):986-988. PubMed ID: 29952103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.
    Ratner N; Miller SJ
    Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
    Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
    J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased rate of missense/in-frame mutations in individuals with NF1-related pulmonary stenosis: a novel genotype-phenotype correlation.
    Ben-Shachar S; Constantini S; Hallevi H; Sach EK; Upadhyaya M; Evans GD; Huson SM
    Eur J Hum Genet; 2013 May; 21(5):535-9. PubMed ID: 23047742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-exome sequencing revealed a likely pathogenic variant in NF1 causing neurofibromatosis type I and Arrhythmogenic Cardiomyopathy.
    Pourirahim M; Houshmand G; Abdolkarimi L; Maleki M; Kalayinia S
    BMC Cardiovasc Disord; 2024 Apr; 24(1):220. PubMed ID: 38654147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type I: mutation spectrum of NF1 in spanish patients.
    Palma Milla C; Lezana Rosales JM; López Montiel J; Andrés Garrido LD; Sánchez Linares C; Carmona Tamajón S; Torres Fernández C; Sánchez González P; Franco Freire S; Benito López C; López Siles J
    Ann Hum Genet; 2018 Nov; 82(6):425-436. PubMed ID: 30014477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical diagnosis of neurofibromatosis type I in multiple family members due to cosegregation of a unique balanced translocation with disruption of the NF1 locus: Testing considerations for accurate diagnosis.
    Smith RB; Solem EP; Metz EC; Wheeler FC; Phillips JA; Yenamandra A
    Am J Med Genet A; 2021 Apr; 185(4):1222-1227. PubMed ID: 33415784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases With Pigmentary Features Only.
    Evans DG; Bowers N; Burkitt-Wright E; Miles E; Garg S; Scott-Kitching V; Penman-Splitt M; Dobbie A; Howard E; Ealing J; Vassalo G; Wallace AJ; Newman W; ; Huson SM
    EBioMedicine; 2016 May; 7():212-20. PubMed ID: 27322474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype.
    Pasmant E; Sabbagh A; Spurlock G; Laurendeau I; Grillo E; Hamel MJ; Martin L; Barbarot S; Leheup B; Rodriguez D; Lacombe D; Dollfus H; Pasquier L; Isidor B; Ferkal S; Soulier J; Sanson M; Dieux-Coeslier A; Bièche I; Parfait B; Vidaud M; Wolkenstein P; Upadhyaya M; Vidaud D;
    Hum Mutat; 2010 Jun; 31(6):E1506-18. PubMed ID: 20513137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.